1-3 of 3
Ypke V. J. M. van Oosterhout
Close
Sort by
Journal Articles

Results from an Expanded Access Program of Anti-CD3/CD7 Immunotoxin Combination (T-Guard®) for the Treatment of Steroid-Refractory Acute Gvhd

Lenneke F J Groningen, Christoph Groth, MD, Manita E J Bremmers, Eric G Hooren, Ypke V J M van Oosterhout, Nicole M A Blijlevens, Matthias Stelljes, Walter J F M van der Velden
Journal: Blood
Blood (2019) 134 (Supplement_1): 4553.
https://doi.org/10.1182/blood-2019-122923
Published: 2019
Journal Articles

A Phase I/II Study on the Anti-CD3/CD7 Immunotoxin Combination (T-GuardTM) for the Treatment of Steroid-Refractory Acute Gvhd

Christoph Groth, MD, Lenneke F J Groningen, Manita E J Bremmers, Frank W M B Preijers, Harry Dolstra, Tiago R Matos, Christian Reicherts, Eric G van Hooren, Ypke V J M van Oosterhout, John E Levine, MD, James L Ferrara, Nicole M A Blijlevens, Matthias Stelljes, MD, Walter J F M van der Velden
Journal: Blood
Blood (2017) 130 (Supplement 1): 513.
https://doi.org/10.1182/blood.V130.Suppl_1.513.513
Published: 2017
Journal Articles

A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease

Clinical Trials & Observations
Ypke V. J. M. van Oosterhout, Liesbeth van Emst, Anton V. M. B. Schattenberg, Wil J. M. Tax, Dirk J. Ruiter, Hergen Spits, Fokke M. Nagengast, Roos Masereeuw, Sabine Evers, Theo de Witte, Frank W. M. B. Preijers
Journal: Blood
Blood (2000) 95 (12): 3693–3701.
https://doi.org/10.1182/blood.V95.12.3693
Published: 2000